0001759143-23-000004.txt : 20231228 0001759143-23-000004.hdr.sgml : 20231228 20231228172851 ACCESSION NUMBER: 0001759143-23-000004 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20231228 DATE AS OF CHANGE: 20231228 EFFECTIVENESS DATE: 20231228 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Stingray Therapeutics, Inc. CENTRAL INDEX KEY: 0001759143 ORGANIZATION NAME: IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-477596 FILM NUMBER: 231523551 BUSINESS ADDRESS: STREET 1: HEALTH WILDCATTERS INCUBATOR STREET 2: 3000 PEGASUS PARK DR., SUITE 1330 CITY: DALLAS STATE: TX ZIP: 75247 BUSINESS PHONE: 317-517-9500 MAIL ADDRESS: STREET 1: HEALTH WILDCATTERS INCUBATOR STREET 2: 3000 PEGASUS PARK DR., SUITE 1330 CITY: DALLAS STATE: TX ZIP: 75247 D/A 1 primary_doc.xml X0708 D/A LIVE 0001759143 Stingray Therapeutics, Inc. Health Wildcatters Incubator 3000 Pegasus Park Dr, Suite 1330 Dallas TX TEXAS 75247 317-517-9500 DELAWARE None None Corporation true Jonathan P. Northrup Health Wildcatters Incubator 3000 Pegasus Park Dr., Suite 1330 Dallas TX TEXAS 75247 Executive Officer Director Sunil Sharma Health Wildcatters Incubator 3000 Pegasus Park Dr., Suite 1330 Dallas TX TEXAS 75247 Executive Officer Director Uma Bhatt Health Wildcatters Incubator 3000 Pegasus Park, Suite 1330 Dallas TX TEXAS 75247 Executive Officer Director Biotechnology Decline to Disclose 06b true 0001759143-23-000001 2023-01-23 false true false 0 6668926 6612080 56846 Total Amount Sold includes the cancellation of aggregate amount outstanding under existing convertible notes and amount invested under SAFEs previously issued by the Company. false 52 0 0 0 false Stingray Therapeutics, Inc. /s/ JONATHAN NORTHRUP Jonathan Northrup Chief Executive Officer 2023-12-27